View in EDS

Real‐World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.

Saved in:
Bibliographic Details
Title: Real‐World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.
Authors: Barreiro‐de Acosta, Manuel1 (AUTHOR) manubarreiro@hotmail.com, Zabana, Yamile2 (AUTHOR), Nieto‐García, Laura1 (AUTHOR), Poncela, Marta3 (AUTHOR), Aguas, Mariam4 (AUTHOR), Martínez‐Cuevas, Cristina5 (AUTHOR), Argüelles‐Arias, Federico6 (AUTHOR), Calvo, Marta7 (AUTHOR), Gargallo‐Puyuelo, Carla J.8 (AUTHOR), Zabalza, Lucía9 (AUTHOR), Trastoy, Pilar Varela10 (AUTHOR), Boscá‐Watts, Maia M.11 (AUTHOR), Ceballos, Daniel12 (AUTHOR), Pascual, Cristina Martínez13 (AUTHOR), Rodríguez‐Moranta, Francisco14 (AUTHOR), de Castro Parga, María Luisa15 (AUTHOR), Suárez, Patricia16 (AUTHOR), Camps, Blau17 (AUTHOR), Royo, Vanesa18 (AUTHOR), Baston‐Rey, Iria1 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Jun2026, p1. 11p. 4 Illustrations.
Database: Academic Search Ultimate
Description
ISSN:02692813
DOI:10.1111/apt.70783